An estimated 30 million Americans have sleep apnea, which is defined as recurring episodes of partial or complete airway ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

Resmed CEO Mick Farrell addressed the latest potential threats to the CPAP therapy market during a recent webcast: The ...

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with OSA.

Whether your snoring originates from your throat or nose, the best anti-snore devices can help open airways or adjust your posture to help ease the problem.

The first oral pill for obstructive sleep apnea (OSA) could be around the corner after pharmaceutical company Apnimed Inc.

This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the ...

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative pressure devices compete?

Sleep apnea and fatty liver disease often occur together and share many similar risk factors. Sleep apnea, especially obstructive sleep apnea (OSA), causes repeated pauses in breathing during sleep.

Rising temperatures, amplified by climate change, are contributing to an increase in cases of sleep apnea, according to a new study.

For the estimated 54 million Americans with obstructive sleep apnea, bedtime isn't refreshing. Their airways are partially blocked during sleep, leading to daytime grogginess and lasting health ...

Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...